Results 41 to 50 of about 76,161 (283)
Journal of Medicine in Scientific Research, 2019 Introduction Retrograde transcatheter closure of perimembranous aneurysmal ventricular septal defects (pmVSD) can be a better option for transcatheter closure of ventricular septal defect with device placement into ventricular septal aneurysm with fewer ...
Rania Diaa Abou Shokka +2 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Mitral annular calcification with mitral valve disease is a challenging problem that could necessitate surgical mitral valve replacement (SMVR). Transcatheter mitral valve replacement (TMVR) is emerging as a feasible alternative in high‐risk patients ...
Sophia L. Alexis +13 more
doaj +1 more source
Application of and Prospects for 3-Dimensional Printing in Transcatheter Mitral Valve Interventions
Reviews in Cardiovascular Medicine, 2023 Mitral valve (MV) disease is one of the most common valvular diseases that endangers health status. A variety of catheter-based interventions have been developed to treat MV disease.
Yu Mao, Yang Liu, Mengen Zhai, Jian Yang
doaj +1 more source
Respiratory Trajectory after Invasive Interventions for Patent Ductus Arteriosus of Preterm Infants
Children, 2021 Invasive interventions have been conducted in preterm infants with significant patent ductus arteriosus (PDA) when medical treatment has failed, and methods of invasive intervention have been reported. Surgical ligation via lateral thoracotomy has been a
Yu-Jen Wei +7 more
doaj +1 more source
Early stentframe thrombosis complicating transcatheter valve in transcatheter valve implantation [PDF]
European Heart Journal, 2016 A 62-year-old woman underwent transcatheter aortic valve implantation (TAVI) for severe low-flow low-gradient stenosis of a bicuspid aortic valve (Supplementary material online, Figure 2 ). She was declined for open heart surgery because of severe left ventricular dysfunction.
van Gils, Lennart +3 more
openaire +3 more sources
Transcatheter treatment for tricuspid valve disease.
, 2021 Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve ...
Maisano, Francesco +27 more
core +1 more source
Similar 5-Year Survival in Transfemoral and Transapical TAVI Patients: A Single-Center Experience
Bioengineering, 2023 Transapical transcatheter aortic valve implantation (TA-TAVI) is generally considered to be associated with increased morbidity and mortality compared with transfemoral transcatheter aortic valve implantation TAVI (TF-TAVI). We aimed to compare different
Constantin Mork +6 more
doaj +1 more source
Transcatheter Treatment of Mitral Regurgitation
Journal of Clinical Medicine, 2022 Mitral valve disease, and in particular mitral regurgitation, is a common clinical entity. Until recently, surgical repair and replacement were the only therapeutic options available, leaving many patients untreated mostly due to excessive surgical risk.
Angela McInerney +15 more
openaire +3 more sources
Circulation: Cardiovascular Interventions, 2021 Background: Transcatheter aortic valve replacement (TAVR) has determined a paradigm shift in the treatment of patients with severe aortic stenosis. However, the durability of bioprostheses is still a matter of concern, and little is known about the management of degenerated TAV.
Luca Testa +38 more
openaire +5 more sources
Advanced Science, EarlyView.Conjugated poly(imide dioxime)‐based microspheres establish a radiometal coordination‐driven conformational interlocked network with ultra‐high radiostability. This platform enables low‐temperature, multi‐radionuclide labeling for SPECT/PET/MRI imaging and radionuclide therapy. Mechanistic insights from EXAFS and DFT reveal enhanced stability, while in
Xiao Xu +10 more
wiley +1 more source